Literature DB >> 30401547

Vasomotor Symptoms Across the Menopause Transition: Differences Among Women.

Nancy E Avis1, Sybil L Crawford2, Robin Green3.   

Abstract

Vasomotor symptoms (VMS) are the primary menopausal symptoms, occurring in up 80% of women and peaking around the final menstrual period. The average duration is 10 years, longer in women with an earlier onset. Compared with non-Hispanic white women, black and Hispanic women are more likely and Asian women are less likely to report VMS. Risk factors include greater body composition (in the early stage of menopausal transition), smoking, anxiety, depression, sensitivity to symptoms, premenstrual syndrome, lower education, and medical treatments, such as hysterectomy, oophorectomy, and breast cancer-related therapies. VMS patterns over time and within higher-risk subgroups are heterogeneous across women.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hot flashes; Menopause; Night sweats; Vasomotor symptoms

Mesh:

Year:  2018        PMID: 30401547      PMCID: PMC6226273          DOI: 10.1016/j.ogc.2018.07.005

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  92 in total

1.  Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women.

Authors:  E W Freeman; M D Sammel; J A Grisso; M Battistini; B Garcia-Espagna; L Hollander
Journal:  J Womens Health Gend Based Med       Date:  2001 Jan-Feb

2.  Symptom clusters during the late reproductive stage through the early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Lori A Cray; Nancy Fugate Woods; Jerald R Herting; Ellen Sullivan Mitchell
Journal:  Menopause       Date:  2012-08       Impact factor: 2.953

Review 3.  The roles of biologic and nonbiologic factors in cultural differences in vasomotor symptoms measured by surveys.

Authors:  Sybil L Crawford
Journal:  Menopause       Date:  2007 Jul-Aug       Impact factor: 2.953

4.  Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation.

Authors:  Ellen B Gold; Alicia Colvin; Nancy Avis; Joyce Bromberger; Gail A Greendale; Lynda Powell; Barbara Sternfeld; Karen Matthews
Journal:  Am J Public Health       Date:  2006-05-30       Impact factor: 9.308

5.  Normative model for cold pressor test.

Authors:  N E Walsh; L Schoenfeld; S Ramamurthy; J Hoffman
Journal:  Am J Phys Med Rehabil       Date:  1989-02       Impact factor: 2.159

6.  A prospective study of the frequency of acute menopausal symptoms in Hong Kong Chinese women.

Authors:  C J Haines; T K Chung; D H Leung
Journal:  Maturitas       Date:  1994-03       Impact factor: 4.342

7.  The role of anxiety and hormonal changes in menopausal hot flashes.

Authors:  Ellen W Freeman; Mary D Sammel; Hui Lin; Clarisa R Gracia; Shiv Kapoor; Tahmina Ferdousi
Journal:  Menopause       Date:  2005 May-Jun       Impact factor: 2.953

8.  Predictors of difficulty when discontinuing postmenopausal hormone therapy.

Authors:  Deborah Grady; Bruce Ettinger; Anna N A Tosteson; Alice Pressman; Judith L Macer
Journal:  Obstet Gynecol       Date:  2003-12       Impact factor: 7.661

9.  Vasomotor and sexual symptoms in older Australian women: a cross-sectional study.

Authors:  Berihun M Zeleke; Robin J Bell; Baki Billah; Susan R Davis
Journal:  Fertil Steril       Date:  2015-10-09       Impact factor: 7.329

10.  Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study.

Authors:  Aleksandra Gentry-Maharaj; Chloe Karpinskyj; Clara Glazer; Matthew Burnell; Andy Ryan; Lindsay Fraser; Anne Lanceley; Ian Jacobs; Myra S Hunter; Usha Menon
Journal:  Menopause       Date:  2015-04       Impact factor: 2.953

View more
  17 in total

1.  Citalopram improves vasomotor syndrome and urogenital syndrome of menopause in Mexican women: a randomized clinical trial.

Authors:  Patricia Loranca-Moreno; Juan Moises Ocampo-Godínez; Alan Rios-Espinosa; Magdalena Cruz-Luna; Carolina Garmendia-Gallardo; Merle Yasmin Hernández-Castañón; Verónica Yazmin Hernández-Hernández; Paula Mariana Sánchez-Tinoco; Alma Bajonero-Domínguez; Jael Adrián Vergara Lope-Núñez; Marco Antonio Álvarez-Pérez; José Luis González-Quiroz
Journal:  Arch Gynecol Obstet       Date:  2022-08-23       Impact factor: 2.493

2.  Talking about sexual health during survivorship: understanding what shapes breast cancer survivors' willingness to communicate with providers.

Authors:  Mollie Rose Canzona; Carla L Fisher; Kevin B Wright; Christy J W Ledford
Journal:  J Cancer Surviv       Date:  2019-11-18       Impact factor: 4.442

3.  Association of sleep quality with telomere length, a marker of cellular aging: A retrospective cohort study of older adults in the United States.

Authors:  Chibuzo Iloabuchi; Kim E Innes; Usha Sambamoorthi
Journal:  Sleep Health       Date:  2020-03-27

4.  Electroacupuncture versus Sham Acupuncture for Perimenopausal Insomnia: A Randomized Controlled Clinical Trial.

Authors:  Shanshan Li; Zhaoqin Wang; Huangan Wu; Hongyu Yue; Ping Yin; Wei Zhang; Lixing Lao; Yiqun Mi; Shifen Xu
Journal:  Nat Sci Sleep       Date:  2020-12-22

5.  The relationship between social support, stressful events, and menopause symptoms.

Authors:  Megan Arnot; Emily H Emmott; Ruth Mace
Journal:  PLoS One       Date:  2021-01-27       Impact factor: 3.240

6.  Vasomotor symptoms, sleep problems, and depressive symptoms in community-dwelling Japanese women.

Authors:  Makiko Tomida; Rei Otsuka; Chikako Tange; Yukiko Nishita; Tomomi Kimura; Matthias Stoelzel; Keiko Tanaka-Amino; Hiroshi Shimokata; Masakazu Terauchi
Journal:  J Obstet Gynaecol Res       Date:  2021-07-18       Impact factor: 1.697

7.  Hypertensive disorders of pregnancy and menopausal symptoms: a cross-sectional study from the data registry on experiences of aging, menopause, and sexuality.

Authors:  Stephanie S Faubion; Amanda King; Andrea G Kattah; Carol L Kuhle; Richa Sood; Juliana M Kling; Kristin C Mara; Ekta Kapoor
Journal:  Menopause       Date:  2020-08-17       Impact factor: 3.310

Review 8.  Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.

Authors:  Rossella E Nappi; Ellis Martini; Laura Cucinella; Silvia Martella; Lara Tiranini; Alessandra Inzoli; Emanuela Brambilla; David Bosoni; Chiara Cassani; Barbara Gardella
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-21       Impact factor: 5.555

9.  Current ecology, not ancestral dispersal patterns, influences menopause symptom severity.

Authors:  Yuping Yang; Megan Arnot; Ruth Mace
Journal:  Ecol Evol       Date:  2019-11-05       Impact factor: 2.912

10.  Identifying the Factors That Affect Depressive Symptoms in Middle-Aged Menopausal Women: A Nationwide Study in Korea.

Authors:  Kisook Kim
Journal:  Int J Environ Res Public Health       Date:  2020-11-17       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.